Becton, Dickinson and Company (BD) is a global medical technology company with more than 125 years of operating history. With approximately 75,000 associates and a presence in nearly every country, BD organises its work across three business segments: Medical, Life Sciences, and Interventional. The company delivers billions of products annually and invests more than $1 billion each year in research and development.
BD's technical work spans medical device engineering, diagnostics, life sciences, and interventional technologies. The company credits itself with introducing the first safety-engineered syringe and pioneering automated diagnostic systems - areas that reflect its broader focus on patient safety, clinical operations, and diagnostic accuracy. Engineering and R&D teams work across the full product lifecycle, from early-stage research through to large-scale manufacturing and deployment.
Technology roles at BD sit at the intersection of software, hardware, and healthcare infrastructure. The company's scale - billions of devices and diagnostic interactions annually, across nearly every healthcare system in the world - means that technical decisions carry significant real-world consequence. Core domains include automated diagnostic systems, medical device engineering, clinical operations optimisation, and the data and software systems that support them.
